|

The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT) Study

RECRUITINGSponsored by University of Florida
Actively Recruiting
SponsorUniversity of Florida
Started2001-01
Est. completion2050-01
Eligibility
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT00500123

Summary

The Alpha-1 Coded Testing (ACT) Study was established to study genetic testing and outcomes of individuals at risk for alpha-1 antitrypsin deficiency.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* Individuals of any age at risk for alpha-1 antitrypsin deficiency on the basis of symptoms or family genetic risk.

Exclusion Criteria:

* Any person who has already had genotype and AAT level testing completed and has a qualified result.

Conditions2

Alpha 1-Antitrypsin DeficiencyLiver Disease

Locations1 site

University of Florida
Gainesville, Florida, 32610
Michelle Owens, RN, BSN352-273-6339Sandra.Owens@medicine.ufl.edu

Browse More Trials

Liver Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.